Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novanuit Triple Action for Sleep Quality
NCT03514732Phase 1Completed
- Sponsor
- Sanofi
- Start
- Mar 2017
- Primary completion
- Jul 2017
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Sanofi. Primary endpoint: Sleep quality global score at Day 21. Started Mar 2017; status: completed.
Beyond the preview
Go deeper on NCT03514732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03514732.